Regulation of genome stability by SENP6 was recently linked to tumor development and progression in MYC-driven B-cell lymphoma27, highlighting that a better understanding of SUMO-polymer signaling and deconjugation may provide novel insights that could enable exploiting this pathway for anticancer therapy. The gene discussed is MYC; the disease is neoplasm.